Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Connolly

Circulation

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Circulation|May 9, 2012
Permanent pacemaker therapy for neurally mediated syncopeStuart J Connolly
Circulation|February 16, 2006
Use and misuse of surrogate outcomes in arrhythmia trialsStuart J Connolly
Circulation|February 5, 2019
Idarucizumab for Dabigatran-Related Gastrointestinal BleedsDeborah M Siegal, Stuart J Connolly
Circulation|November 2, 2020
Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral AnticoagulationGanesan Karthikeyan, Stuart J Connolly, Salim Yusuf
Circulation|June 3, 2015
Letter by Longtin et al regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry"Yves Longtin, Stuart J Connolly, Andrew D Krahn
Circulation|November 11, 2009
Left atrial appendage occlusion does not eliminate the need for warfarinRichard P Whitlock, Jeff S Healey, Stuart J Connolly
Circulation|July 25, 2007
Challenges of establishing new antithrombotic therapies in atrial fibrillationStuart J Connolly, John Eikelboom, Martin O'Donnell, et al.
Circulation|July 3, 2002
Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysisEugene Crystal, Stuart J Connolly, Khaled Sleik, et al.
Circulation|April 14, 2021
Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral AnticoagulationAlexander P Benz, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|December 8, 2010
Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT)Paul Dorian, Stefan H Hohnloser, Kevin E Thorpe, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Circulation|May 9, 2012
Permanent pacemaker therapy for neurally mediated syncopeStuart J Connolly
Circulation|February 16, 2006
Use and misuse of surrogate outcomes in arrhythmia trialsStuart J Connolly
Circulation|February 5, 2019
Idarucizumab for Dabigatran-Related Gastrointestinal BleedsDeborah M Siegal, Stuart J Connolly
Circulation|November 2, 2020
Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral AnticoagulationGanesan Karthikeyan, Stuart J Connolly, Salim Yusuf
Circulation|June 3, 2015
Letter by Longtin et al regarding article, "Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry"Yves Longtin, Stuart J Connolly, Andrew D Krahn
Circulation|November 11, 2009
Left atrial appendage occlusion does not eliminate the need for warfarinRichard P Whitlock, Jeff S Healey, Stuart J Connolly
Circulation|July 25, 2007
Challenges of establishing new antithrombotic therapies in atrial fibrillationStuart J Connolly, John Eikelboom, Martin O'Donnell, et al.
Circulation|July 3, 2002
Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysisEugene Crystal, Stuart J Connolly, Khaled Sleik, et al.
Circulation|April 14, 2021
Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral AnticoagulationAlexander P Benz, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|December 8, 2010
Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT)Paul Dorian, Stefan H Hohnloser, Kevin E Thorpe, et al.
Pageof 6